Point of care testing (POCT) helps in the rapid performance of diagnostic tests despite patient being at the point of care facility. This helps in obtaining the results immediately rather than waiting for hours or even days outside the laboratory. POCT has become significant part of patient care at various health care facilities. Point-of-care testing includes glucometer, lipid analysers, coagulation analysers, and hematology analysers among others. These tests are planned so that they can be used near the site of patients’ location which does not require permanent space and can be performed in non-laboratory settings such as in the physician’s office, ambulance, home, field, and hospital.
The Global Point-Of- Care Testing Market has been segmented On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Based on prescription mode, the global point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing. On the basis of distribution channel, the market is segmented into direct tenders and retail. Based on end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.
The global point-of-care testing market is segmented into geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. These regions are further classified on the basis of country, into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
Major Players Operating in this market:
Abbott Laboratories, Inc., Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, bioMérieux, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedical.
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America),Rest of World)).